Maria JoseSoler BarcelonaSpain

• AKI Due to Chemotherapy
  Diana CarolinaVargas Angel Speaker dcvargas@husi.org.coColombia
• AKI Due to Targeted Therapy
  MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan
• AKI Due to Immunotherapy
  Maria JoseSoler Speaker mjsoler01@gmail.comSpain
• Roundtable Discussion
  KenarJhaveri Moderator Kjhaveri@northwell.eduUnited States

• Welcome & Introduction
  MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan
• Orchestrating Excellence: KDIGO’s Guidance on the Management of IgA Nephropathy
  Sydney Tang Speaker scwtang@hku.hkHong Kong, China
• Setting the Tempo: The Importance of Early Diagnosis and Treatment in IgA Nephropathy
  Maria JoseSoler Speaker mjsoler01@gmail.comSpain
• A Harmonious Approach: Simultaneously Targeting Both Drivers
  VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustralia
• A Note of Hope: Reimagining the Outcomes for Patients With IgA Nephropathy
  MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan
• Summary & Close
  MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan

• Cancer Screening in Kidney Transplant Recipients and Patients on Dialysis
  Chi Yuen SimonCheung Speaker simoncycheung@gmail.comHong Kong, China
• Chronic Kidney Disease After Childhood Cancer
  Maria JoseSoler Speaker mjsoler01@gmail.comSpain
• Palliative Care in Cancer Patients With Kidney Disease: The Nephrologist's Role
• Q&A